DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
- 1 June 1978
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 311 (8077) , 1286-1289
- https://doi.org/10.1016/s0140-6736(78)91269-2
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975
- Studies of Platelet and Fibrinogen Kinetics in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1970
- The effect of salicylates on the hemostatic properties of platelets in manJournal of Clinical Investigation, 1968
- Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the RabbitNature, 1965
- EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOURThe Lancet, 1965